Shandong Sinobioway Biomedicine Co., Ltd. (SHE:002581)

SHE:002581 Revenue

Shandong Sinobioway Biomedicine had revenue of 43.86M CNY in the quarter ending March 31, 2026, with 24.15% growth. This brings the company's revenue in the last twelve months to 283.34M, down -9.17% year-over-year. In the year 2025, Shandong Sinobioway Biomedicine had annual revenue of 274.81M, down -23.75%.

• Revenue (ttm): 283.34M
• Revenue Growth: -9.17%
• P/S Ratio: 8.48
• Revenue / Employee: 595.26K
• Employees: 476
• Market Cap: 2.40B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	274.81M	-85.60M	-23.75%
Dec 31, 2024	360.41M	-69.39M	-16.14%
Dec 31, 2023	429.79M	72.71M	20.36%
Jan 1, 2023	357.08M	-45.63M	-11.33%
Jan 1, 2022	402.71M	125.88M	45.47%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 10, 2026

Data Sources Report a data error